CD44 and small cell lung carcinoma: Highly tumorigenic and self-renewing cells, with properties like CSCs, have been reported in both SCLC and NSCLC using CD133+, CD44+, CD24+, and CD133+ cell surface markers or high ALDHA1 activity [21, 30–33].